Involvement of the mu-opiate receptor in peripheral analgesia
- PMID: 2557556
- DOI: 10.1016/0306-4522(89)90279-0
Involvement of the mu-opiate receptor in peripheral analgesia
Abstract
The intradermal injection of mu (morphine, Tyr-D-Ala-Gly-NMe-Phe-Gly-ol and morphiceptin), kappa (trans-3,4-dichloro-N-methyl-N[2-(1-pyrrolidinyl) cyclohexyl]benzeneactemide) and delta ([D-Pen2.5]-enkephalin and [D-Ser2]-[Leu]enkephalin-Thr) selective opioid-agonists, by themselves, did not significantly affect the mechanical nociceptive threshold in the hindpaw of the rat. Intradermal injection of mu, but not delta or kappa opioid-agonists, however, produced dose-dependent inhibition of prostaglandin E2-induced hyperalgesia. The analgesic effect of the mu-agonist morphine was dose-dependently antagonized by naloxone and prevented by co-injection of pertussis toxin. Morphine did not, however, alter the hyperalgesia induced by 8-bromo cyclic adenosine monophosphate. We conclude that the analgesic action of opioids on the peripheral terminals of primary afferents is via a binding site with characteristics of the mu-opioid receptor and that this action is mediated by inhibition of the cyclic adenosine monophosphate second messenger system.
Similar articles
-
Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.J Pharmacol Exp Ther. 1988 Feb;244(2):456-62. J Pharmacol Exp Ther. 1988. PMID: 2831341
-
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.J Pharmacol Exp Ther. 1989 Mar;248(3):1269-75. J Pharmacol Exp Ther. 1989. PMID: 2539460
-
Peptide opioid antagonist separates peripheral and central opioid antitransit effects.J Pharmacol Exp Ther. 1987 Nov;243(2):492-500. J Pharmacol Exp Ther. 1987. PMID: 2824748
-
Morphine receptors in immunocytes and neurons.Adv Neuroimmunol. 1994;4(2):69-82. doi: 10.1016/s0960-5428(05)80002-6. Adv Neuroimmunol. 1994. PMID: 7952830 Review.
-
The endogenous opioid system and clinical pain management.AACN Clin Issues. 2005 Jul-Sep;16(3):291-301. doi: 10.1097/00044067-200507000-00003. AACN Clin Issues. 2005. PMID: 16082232 Review.
Cited by
-
Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.Neuroscience. 2019 Feb 1;398:64-75. doi: 10.1016/j.neuroscience.2018.11.051. Epub 2018 Dec 7. Neuroscience. 2019. PMID: 30529265 Free PMC article.
-
The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels.Br J Pharmacol. 2000 Jan;129(1):110-4. doi: 10.1038/sj.bjp.0703038. Br J Pharmacol. 2000. PMID: 10694209 Free PMC article.
-
Atorvastatin inhibits inflammatory hypernociception.Br J Pharmacol. 2006 Sep;149(1):14-22. doi: 10.1038/sj.bjp.0706836. Epub 2006 Jul 24. Br J Pharmacol. 2006. PMID: 16865092 Free PMC article.
-
Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.J Neurosci. 2015 Sep 9;35(36):12502-17. doi: 10.1523/JNEUROSCI.1673-15.2015. J Neurosci. 2015. PMID: 26354917 Free PMC article.
-
Peripheral delta opioid receptors require priming for functional competence in vivo.Eur J Pharmacol. 2009 Jan 14;602(2-3):283-7. doi: 10.1016/j.ejphar.2008.11.028. Epub 2008 Nov 25. Eur J Pharmacol. 2009. PMID: 19063879 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials